Products - Spinal conditions | Topic | NICE

Showing 4 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Intrathecal onasemnogene abeparvovec for treating spinal muscular atrophy ID6556
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
28 October 2026
Oxybutynin hydrochloride for managing neurogenic detrusor overactivity in people 6 years and over with spinal cord injury or spina bifida [ID5089]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Neuro-Cells stem-cell treatment for traumatic spinal cord injury [ID6588]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC